Hims & Hers Health HIMS
Hims & Hers Health FY 2025: revenue $2.3B, up 59%; diluted EPS $0.51
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001773751-26-000022
Key figures from this report
These are the numbers Hims & Hers Health reported for the year ended Dec 31, 2025, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Revenue$2.3B+59% from $1.5B in FY 202410-K income statement, on EDGAR
- Net income$128.4M+2% from $126.0M in FY 202410-K income statement, on EDGAR
- Diluted EPS$0.51−4% from $0.53 in FY 202410-K income statement, on EDGAR
- Cash and cash equivalents$228.6M+4% from $220.6M in FY 2024Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
- Cash from operations$300.0M+19% from $251.1M in FY 202410-K cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 8011 and related industry codes: the same peer list as the financial tables.
- Teladoc Health TDOC public float $1.5B, Jun 30, 2025
- LifeMD LFMD public float $512M, Jun 30, 2025
- Starling Oncology TOI public float $137M, Jun 30, 2025
- Airsculpt Technologies AIRS public float $80M, Jun 30, 2025
- SBC Medical Group Holdings SBC public float $48M, Jun 30, 2025